[ Price : $8.95]
J&J touts positive overall survival results of its Carvykti in a Phase 3 trial in patients with relapsed or lenalidomide-refractor...[ Price : $8.95]
Checkpoint Therapeutics says it has completed the resubmission of a BLA for its cosibelimab cancer treatment.[ Price : $8.95]
FDA approves Samsung Bioepis Pyzchiva as an interchangeable biosimilar for Janssens Stelara.[ Price : $8.95]
FDA approves a Genentech Vabysmo prefilled syringe to treat three retinal disorders with the same medicine as Vabysmo vials.[ Price : $8.95]
Venable attorney Robert Schwartz says an updated FDA guidance with alternatives to switching studies for demonstrating biosimilar ...[ Price : $8.95]
FDA warns Indias Sun Pharmaceutical Industries about repeat CGMP violations at one drug manufacturing facility and in other compan...[ Price : $8.95]
Attorneys in several law firms analyze the opportunities and risks for FDA-regulated companies arising from the Supreme Court deci...[ Price : $8.95]
FDA warns the ozempen.com Web site to stop offering unapproved and misbranded drugs to U.S. consumers.